R
61
2
NOV
45
-5
CNP
71
-2
MAT
51
8
PRGO
46
-4
LEN
15
-3
BEN
30
-4
PX
49
-13
PSA
50
-5
LLY
59
2
PBI
40
-12
JCI
54
3
KR
61
2
A
43
2
ROST
47
-2
GME
60
6
RIG
25
-3
PM
58
-2
ALLE
35
-2
PDCO
69
-2
R
61
2
NOV
45
-5
CNP
71
-2
MAT
51
8
PRGO
46
-4
LEN
15
-3
BEN
30
-4
PX
49
-13
PSA
50
-5
LLY
59
2
PBI
40
-12
JCI
54
3
KR
61
2
A
43
2
ROST
47
-2
GME
60
6
RIG
25
-3
PM
58
-2
ALLE
35
-2
PDCO
69
-2
Financhill
Back

Ultra Clean Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

UCTT
Ultra Clean Holdings

Last Price:
$24.25
Seasonality Move:
6.53%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Sell
33
Ultra Clean Holdings (UCTT) is a Sell

Is Ultra Clean Holdings a Buy, Sell or Hold?

  • The current Ultra Clean Holdings [UCTT] share price is $24.25. The Score for UCTT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UCTT Stock Price Chart

What is Ultra Clean Holdings's stock price today?

  • The Ultra Clean Holdings share price today is $24.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

UCTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.56 Sell
Relative Strength Index (14 RSI): 35.1 Sell
Chaikin Money Flow: 112470 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.38 - 34.42) Sell
Bollinger Bands (100): (29.8 - 39.64) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

UCTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.84 Sell
20-day SMA: 26.02 Sell
50-day SMA: 32.85 Sell
200-day SMA: 38.33 Sell
8-day EMA: 24.83 Sell
20-day EMA: 26.81 Sell
50-day EMA: 30.84 Sell
200-day EMA: 36.02 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Ultra Clean Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):